ENG rs1085307434: Understanding Hereditary Hemorrhagic Telangiectasia
The variant rs1085307434 is located within the ENG gene, which provides instructions for making the endoglin protein. This specific genetic change has been identified in individuals diagnosed with hereditary hemorrhagic telangiectasia (HHT), a condition characterized by abnormal blood vessel development.
What each genotype means
Typical ENG genotype
This genotype represents the common, non-pathogenic state for this specific location in the ENG gene. It is not associated with the development of hereditary hemorrhagic telangiectasia (HHT) in the context of this variant.
This is the most common genotype found in the general population across all ancestries.
Potential HHT risk variant
This genotype indicates the presence of a rare variant in the ENG gene, which is associated with hereditary hemorrhagic telangiectasia (HHT). HHT is an autosomal dominant condition, meaning a single copy of a pathogenic variant is typically sufficient to influence disease risk; please consult with a genetic counselor or clinician to discuss the clinical significance of this specific finding.
This genotype is extremely rare, as pathogenic variants in the ENG gene are estimated to occur at a very low frequency in the general population.
Potential HHT risk variant
This genotype indicates the presence of two copies of a rare variant in the ENG gene. Because HHT is an autosomal dominant disorder, the presence of this variant is clinically significant and warrants professional medical evaluation to assess for vascular symptoms; please discuss these results with a healthcare provider or genetic specialist.
This genotype is exceptionally rare and is not typically observed in the general population.
What is the rs1085307434 Variant?
The variant rs1085307434 is a specific change in the DNA sequence of the ENG gene. In genomics, a variant represents a difference in the genetic code compared to the most common sequence found in the general population. This particular variant is located on chromosome 9, where the ENG gene resides. Because the ENG gene is critical for maintaining the structural integrity of blood vessels, variations in this region can potentially disrupt normal biological processes. Researchers track these variants to understand how they contribute to specific health conditions. It is important to note that the presence of a variant does not automatically mean an individual will develop a disease; rather, it indicates a change that may influence biological function. Scientists use databases like dbSNP to catalog these variations, allowing for consistent study across different research projects worldwide.
The Role of the ENG Gene
The ENG gene encodes a protein called endoglin, which is primarily found on the surface of endothelial cells—the cells that line the interior of blood vessels. Endoglin plays a vital role in the cardiovascular system by helping to regulate the signaling pathways that control blood vessel formation and repair. When the ENG gene functions correctly, it ensures that blood vessels develop properly and maintain their structural stability. However, when mutations occur in this gene, the production or function of the endoglin protein can be impaired. This impairment often leads to a condition known as haploinsufficiency, where the body does not produce enough functional protein to maintain normal vascular health. This disruption is a hallmark of hereditary hemorrhagic telangiectasia (HHT), a disorder that causes blood vessels to form incorrectly, often resulting in fragile vessels that are prone to bleeding.
Research and Clinical Associations
Research has linked variants in the ENG gene to hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Rendu-Weber syndrome. HHT is an autosomal dominant disorder, meaning that a single altered copy of the gene is sufficient to increase the risk of developing the condition. Clinical studies have identified various mutations in ENG among patients presenting with multisystemic vascular dysplasia, which includes telangiectasias (small, dilated blood vessels) and arteriovenous malformations (abnormal connections between arteries and veins). The evidence for the link between ENG mutations and HHT is considered strong in the scientific community, as these mutations are a primary cause of the disease. While rs1085307434 is specifically noted in clinical databases in the context of HHT, the severity and presentation of the condition can vary significantly between individuals, even among those within the same family who carry the same genetic variant.
Population Frequency and Interpretation
The variant rs1085307434 is classified as rare in the general population. In genetic research, a rare variant is one that appears at a very low frequency across diverse ancestral groups. Because it is rare, it is not typically found in large-scale population screening studies, which often focus on more common genetic markers. The rarity of this variant underscores its potential clinical significance, as many disease-causing mutations are not widely distributed in the general public. When interpreting genetic information, it is essential to understand that population frequency is just one piece of the puzzle. Genetic counselors and medical professionals use this data alongside clinical symptoms and family history to provide context. If you have concerns about your genetic profile or family history of vascular conditions, it is recommended to consult with a qualified healthcare provider or a genetic counselor who can interpret these findings in the context of your personal health.
What You Can Do With This Information
Information about genetic variants like rs1085307434 is primarily intended for educational and research purposes. If you have received a report indicating you carry this variant, it is important not to draw medical conclusions on your own. Genetic testing results should always be discussed with a physician or a certified genetic counselor who can explain the implications based on your specific clinical history. They can help determine if further diagnostic testing or screening for vascular malformations is appropriate for you or your family members. You cannot use this information to diagnose yourself or to predict the exact course of a condition. Always consult with your healthcare team before making any decisions regarding your health, and never change or stop any prescribed medications based on genetic data without professional guidance. Your clinician is the best resource for navigating the complexities of genetic health information.
How common is this variant?
The variant rs1085307434 is considered rare, with a very low frequency across global populations as documented in current genetic databases.
Frequently asked questions
What is hereditary hemorrhagic telangiectasia?
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder that causes abnormal blood vessel formation. It often leads to frequent nosebleeds, skin telangiectasias, and potential complications in internal organs like the lungs, liver, or brain.
Does having this variant mean I have HHT?
Not necessarily. While this variant is associated with HHT, genetic testing results must be interpreted by a doctor in the context of your physical symptoms and family history. A genetic variant is a risk factor, not a definitive diagnosis.
Can I get tested for this variant?
Yes, clinical genetic testing for the ENG gene is available through specialized laboratories. You should speak with a genetic counselor or your primary care physician to determine if testing is appropriate for your situation.
Is there a cure for HHT?
There is currently no cure for HHT, but the condition is manageable. Treatment focuses on preventing and treating bleeding complications and monitoring for arteriovenous malformations through regular medical screenings.
How is HHT inherited?
HHT is typically inherited in an autosomal dominant pattern. This means that an individual only needs to inherit one copy of the altered gene from one parent to be at risk for the condition.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1085307434?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ENG
Genetic variant identified in the ENG gene, relevant for clinical screening of vascular disorders.
A known pathogenic mutation in the ENG gene linked to vascular malformations.
Pathogenic variant in the ENG gene associated with hereditary hemorrhagic telangiectasia type 1.
A variant in the ENG gene potentially impacting protein function related to vascular development.
This variant is located within the ENG gene, which is associated with hereditary hemorrhagic telangiectasia.
Clinically significant variant in the ENG gene associated with hereditary hemorrhagic telangiectasia.